Friday, May 22, 2015 6:19:19 AM
http://meetinglibrary.asco.org/content/134277-144
This year $ONCS presented their new , in my assumption, data at the New York Academy of Sciences via a Poster Presentation for IL-12 biologic pathways. "Intratumoral Expression of Plasmid IL-12 Can Increase CD8 TILs and Drive Systemic Anti-Tumor Responses"
Dr. Pierce IMO is trying to develop/find biologic markers that will quickly identify and allow for maximizing IL-12 dosage for each individual cancer recipient at their dosing session. IL-12 dosages are toxic if too high, produce good ORR for small dosages and could possibly produce excellent increased ORR when optimized identified by new found biologic markers.
If Dr. Pierce is successful at optimizing IL-12 dosages then this would be important new data discovery and worthy of 1st time public presentation as detemined by the New York Academy of Sciences.
We await now for full release of the Poster details.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM